Top Story

AAD issues guidance on biologic use during COVID-19

March 24, 2020
In the Journals

Etanercept may have utility in psoriasis among patients with inadequate apremilast response

March 23, 2020
Among patients with psoriasis who showed an inadequate response to apremilast, etanercept was associated with strong response rates and patient-reported outcomes…
FDA News

Baricitinib receives breakthrough therapy designation for alopecia areata

March 16, 2020
The FDA granted breakthrough therapy designation to baricitinib to treat patients with alopecia areata, according to a press release from Eli Lilly and Incyte. …
In the Journals

Oral, topical terbinafine use may be safe in pregnancy

March 13, 2020
Pregnancies exposed to oral or topical terbinafine had no increased risk for major malformations or spontaneous abortion compared with unexposed pregnancies, according…
More Headlines »
Healio Jobs